EPO and anemia (phenotype): Using high-dose EPO for the complete correction of anemia or to achieve a high hemoglobin level, no reduction in the risk of cardiovascular events was observed; rather, there was an increased risk of serious cardiovascular events and mortality (Drueke et al., 2006; Singh et al., 2006; McCullough et al., 2013).